TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Pharmaq Analytiq AS
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
57,514
|
55,623
|
61,590 |
| Financial expenses |
361
|
343
|
61 |
| Earnings before taxes |
-464
|
-4,506
|
-2,879 |
| Total assets |
26,785
|
35,523
|
42,658 |
| Current assets |
12,513
|
18,907
|
22,587 |
| Current liabilities |
13,163
|
20,488
|
27,245 |
| Equity capital |
13,477
|
14,738
|
15,103 |
| - share capital |
729
|
777
|
820 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
50.3%
|
41.5%
|
35.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-0.8%
|
-8.1%
|
-4.7% |
| Return on assets (ROA) |
-0.4%
|
-11.7%
|
-6.6% |
| Current ratio |
95.1%
|
92.3%
|
82.9% |
| Return on equity (ROE) |
-3.4%
|
-30.6%
|
-19.1% |
| Change turnover |
5,308
|
-2,732
|
20,308 |
| Change turnover % |
10%
|
-5%
|
49% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.